CareX SA

About:

CareX SA is a biopharmaceutical company focused on metabolic disease.

Top Investors: Sofinnova Investments, Index Ventures, Gimv, BioMedPartners, Global Life Science Ventures

Description:

CareX SA is a biopharmaceutical company that develops novel treatments for metabolic and immune system disorders which includes diabetes and obesity. The company focuses on metabolic syndrome, a cluster of inter-related disorders of the body’s metabolism, including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol levels, that exposes individuals to the development of type 2 diabetes, heart diseases, and strokes. CareX SA is a France-based company that was founded in 2001 and the company was acquired by 7TM Pharma on May 24, 2006.

Total Funding Amount:

$32M

Headquarters Location:

Illkirch, Alsace, France

Founded Date:

2001-01-01

Contact Email:

info(AT)carex.fr

Founders:

Number of Employees:

Last Funding Date:

2004-03-08

IPO Status:

Private

Industries: